Covidien scores CE Mark for EverFlex peripheral stent, delivery system

Editorial Staff | | Cardiovascular Business | Vascular & Endovascular

Covidien has received CE Mark approval for its EverFlex self-expanding peripheral stent with Entrust delivery system.

The Entrust delivery system is a one-handed delivery system with a triaxial design to offer a 5 Fr profile that is compatible with a 0.035-inch guidewire, Dublin-based Covidien reported. Other features include a range of catheter lengths and a broad stent matrix.

With the Entrust delivery system, physicians can deploy all sizes of the Covidien EverFlex stent on a low 5 Fr profile. The EverFlex stent was evaluated in the DURABILITY II clinical study.

The product will be rolled out in Western Europe in February, according to the company.

Editorial Staff

Related Content

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Stryker acquires Inari Medical for $4.9B
‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Advancing AI for vascular surgery will require a commitment to data integrity
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Genetic predisposition to depression increases CVD risk in women, but not men

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.